Geopolitical tremors are no longer confined to distant maps, they are systemic shocks that hit close to home, impacting the cost and availability of essential goods. The escalating Iran-Israel conflict is a perfect example. What begins as a regional confrontation has swiftly become a global economic disruptor, with immediate and profound consequences for the healthcare industry. 

Tablets are the most prevalent solid dosage form, accounting for approximately 70% of all dispensed medicines. Their versatility in shape, size, and weight, tailored to the drug and route of administration, offers significant advantages.

This blog is the highlight of the changing healthcare landscape from the clinical system to the preventive one. A cornerstone of this modern movement is the ascending role of nutraceuticals. These are not just simple supplements; they are scientifically engineered nutritional products specifically designed to bolster overall health, enhance the body's natural resilience, and maintain internal balance before the onset of disease. Consequently, nutraceuticals are evolving fro

The blog is a highlight of the new economic game-changer agreement. This FTA between India and New Zealand, as a significant step in this direction was the successful conclusion of negotiations for a comprehensive Free Trade Agreement (FTA) between India and New Zealand on December 22, 2025. This pact is notable for its speed, negotiated in less than a year, and marks the seventh major trade agreement for India in the last five years.

The blog is an insight into India's pharmaceutical expertise as global player in the industry. The global healthcare landscape is being fundamentally shaped by the rise of India’s pharmaceutical industry. No longer just a regional player, India has firmly established itself as a pivotal force in ensuring access to medicine worldwide. Impressive figures underscore this influence. India’s pharmaceutical exports soared past USD 30 billion in the fiscal year 2024-25.